Gene · 200315
Papers1,983
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 1,983
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness. | Sci Rep | 2022 | 36100631 | PubTator, text mining | PubMed |
| Differences in integration frequencies and APOBEC3 profiles of five high-risk HPV types adheres to phylogeny. | Tumour Virus Res | 2022 | 36100161 | PubTator, text mining | PubMed |
| APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas. | Ann Oncol | 2022 | 36089134 | PubTator, text mining | PubMed |
| Comprehending the evolution of gene editing platforms for crop trait improvement. | Front Genet | 2022 | 36082000 | PubTator, text mining | PubMed |
| Pronounced sequence specificity of the TET enzyme catalytic domain guides its cellular function. | Sci Adv | 2022 | 36070377 | PubTator, text mining | PubMed |
| Pediatric chordoma associated with tuberous sclerosis complex: A rare case report with a thorough analysis of potential therapeutic molecular targets. | Heliyon | 2022 | 36051260 | PubTator, text mining | PubMed |
| Identifying key genes in CD4+ T cells of systemic lupus erythematosus by integrated bioinformatics analysis. | Front Genet | 2022 | 36046235 | PubTator, text mining | PubMed |
| Programmable RNA base editing with a single gRNA-free enzyme. | Nucleic Acids Res | 2022 | 36029126 | PubTator, text mining | PubMed |
| Molecular Threat of Splicing Factor Mutations to Myeloid Malignancies and Potential Therapeutic Modulations. | Biomedicines | 2022 | 36009519 | PubTator, text mining | PubMed |
| Partitioning of ribonucleoprotein complexes from the cellular actin cortex. | Sci Adv | 2022 | 35984883 | PubTator, text mining | PubMed |
| Occult hepatitis B - the result of the host immune response interaction with different genomic expressions of the virus. | World J Clin Cases | 2022 | 35979101 | PubTator, text mining | PubMed |
| AID function in somatic hypermutation and class switch recombination. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35975606 | PubTator, text mining | PubMed |
| Improvements of nuclease and nickase gene modification techniques for the treatment of genetic diseases. | Front Genome Ed | 2022 | 35958050 | PubTator, text mining | PubMed |
| Unifying Different Cancer Theories in a Unique Tumour Model: Chronic Inflammation and Deaminases as Meeting Points. | Int J Mol Sci | 2022 | 35955853 | PubTator, text mining | PubMed |
| Gene expression patterns associated with multidrug therapy in multibacillary leprosy. | Front Cell Infect Microbiol | 2022 | 35937686 | PubTator, text mining | PubMed |
| The SOS response-associated peptidase (SRAP) domain of YedK catalyzes ring opening of abasic sites and reversal of its DNA-protein cross-link. | J Biol Chem | 2022 | 35934051 | PubTator, text mining | PubMed |
| TP53-dependent toxicity of CRISPR/Cas9 cuts is differential across genomic loci and can confound genetic screening. | Nat Commun | 2022 | 35927263 | PubTator, text mining | PubMed |
| Comprehensive Analysis Identifies and Validates the Tumor Microenvironment Subtypes to Predict Anti-Tumor Therapy Efficacy in Hepatocellular Carcinoma. | Front Immunol | 2022 | 35924239 | PubTator, text mining | PubMed |
| A Novel Type I Interferon Primed Dendritic Cell Subpopulation in TREX1 Mutant Chilblain Lupus Patients. | Front Immunol | 2022 | 35911727 | PubTator, text mining | PubMed |
| Suppression of influenza virus infection by rhinovirus interference - at the population, individual and cellular levels. | Curr Res Microb Sci | 2022 | 35909608 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200315/papers?page=24